Cannabidiol

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Cannabidiol and local guidelines before prescribing.

Anticonvulsant

Mechanism

Anticonvulsant with unclear mechanism.

Uses

Dravet and Lennox-Gastaut syndromes, tuberous sclerosis seizures.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Drowsiness, diarrhoea, reduced appetite, raised transaminases.

Interactions

Raises clobazam levels; valproate increases hepatotoxicity.

Contraindications and cautions

Hepatic impairment

Monitoring

LFT, mood

Pregnancy and breastfeeding

Avoid

Renal and hepatic impairment

Reduce dose in moderate to severe hepatic impairment

Overdose and reversal

Supportive

Special advice

LFT monitoring at baseline and early.

More from the textbook: uses, cautions and other points
Where it is discussed in the book